208 related articles for article (PubMed ID: 20528922)
41. Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter.
Liu M; Whetstine JR; Payton SG; Ge Y; Flatley RM; Matherly LH
Biochem J; 2004 Oct; 383(Pt 2):249-57. PubMed ID: 15214842
[TBL] [Abstract][Full Text] [Related]
42. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
43. Expression of the vascular endothelial growth factor gene is inhibited by p73.
Salimath B; Marmé D; Finkenzeller G
Oncogene; 2000 Jul; 19(31):3470-6. PubMed ID: 10918605
[TBL] [Abstract][Full Text] [Related]
44. Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.
Marcel V; Petit I; Murray-Zmijewski F; Goullet de Rugy T; Fernandes K; Meuray V; Diot A; Lane DP; Aberdam D; Bourdon JC
Cell Death Differ; 2012 May; 19(5):816-26. PubMed ID: 22075982
[TBL] [Abstract][Full Text] [Related]
45. Functions, divergence and clinical value of TAp73 isoforms in cancer.
Logotheti S; Pavlopoulou A; Galtsidis S; Vojtesek B; Zoumpourlis V
Cancer Metastasis Rev; 2013 Dec; 32(3-4):511-34. PubMed ID: 23592418
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
47. Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.
Chun JY; Hu Y; Pinder E; Wu J; Li F; Gao AC
Mol Cancer Ther; 2007 Sep; 6(9):2572-80. PubMed ID: 17876054
[TBL] [Abstract][Full Text] [Related]
48. A functional Sp1 binding site is essential for the activity of the adult liver-specific human insulin-like growth factor II promoter.
Rodenburg RJ; Holthuizen PE; Sussenbach JS
Mol Endocrinol; 1997 Feb; 11(2):237-50. PubMed ID: 9013771
[TBL] [Abstract][Full Text] [Related]
49. Egr-1 upregulates the Alzheimer's disease presenilin-2 gene in neuronal cells.
Renbaum P; Beeri R; Gabai E; Amiel M; Gal M; Ehrengruber MU; Levy-Lahad E
Gene; 2003 Oct; 318():113-24. PubMed ID: 14585504
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia-induced DNp73 stabilization regulates Vegf-A expression and tumor angiogenesis similar to TAp73.
Dulloo I; Hooi PB; Sabapathy K
Cell Cycle; 2015; 14(22):3533-9. PubMed ID: 26267146
[TBL] [Abstract][Full Text] [Related]
51. Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.
Thangasamy A; Rogge J; Ammanamanchi S
J Biol Chem; 2008 Feb; 283(9):5335-43. PubMed ID: 18165235
[TBL] [Abstract][Full Text] [Related]
52. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
[TBL] [Abstract][Full Text] [Related]
53. Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells.
Oh YK; Lee HJ; Jeong MH; Rhee M; Mo JW; Song EH; Lim JY; Choi KH; Jo I; Park SI; Gao B; Kwon Y; Kim WH
Mol Cancer Res; 2008 Jul; 6(7):1232-49. PubMed ID: 18644986
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
Loeffler S; Fayard B; Weis J; Weissenberger J
Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
[TBL] [Abstract][Full Text] [Related]
55. Importance of Sp1 consensus motifs in the MYCN promoter.
Inge TH; Casson LK; Priebe W; Trent JO; Georgeson KE; Miller DM; Bates PJ
Surgery; 2002 Aug; 132(2):232-8. PubMed ID: 12219017
[TBL] [Abstract][Full Text] [Related]
56. Functional characterization of rat gp600/megalin promoter: combination of proximal Sp1 site and JCV repeat is important in rat gp600/megalin promoter activation.
Zhao J; Oleinikov AV; Oleinikova I; Makker SP
Gene; 2001 Mar; 265(1-2):123-31. PubMed ID: 11255015
[TBL] [Abstract][Full Text] [Related]
57. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
[TBL] [Abstract][Full Text] [Related]
58. Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineage.
Yu SJ; Zheng L; Ladanyi M; Asa SL; Ezzat S
Clin Cancer Res; 2004 Oct; 10(19):6750-8. PubMed ID: 15475466
[TBL] [Abstract][Full Text] [Related]
59. Sp1 transcriptionally regulates BRK1 expression in non-small cell lung cancer cells.
Li M; Ling B; Xiao T; Tan J; An N; Han N; Guo S; Cheng S; Zhang K
Gene; 2014 Jun; 542(2):134-40. PubMed ID: 24680773
[TBL] [Abstract][Full Text] [Related]
60. Sp sites contribute to basal and inducible expression of the human TNIP1 (TNFα-inducible protein 3-interacting protein 1) promoter.
Encarnacao PC; Ramirez VP; Zhang C; Aneskievich BJ
Biochem J; 2013 Jun; 452(3):519-29. PubMed ID: 23464785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
